HSPB2 and invasive breast carcinoma: Additionally, multivariable Cox regression analysis revealed that HSPB2 mRNA expression status remained a statistically significant factor of poor OS in BrCa, independent of molecular subtype and prognostic stage (HR = 2.69, 95% CI = 1.33–5.42, p = 0.006).